View Older Stories View More Recent Stories

Dec 22, 2016 07:00AM Horizon Pharma plc Announces Availability of QUINSAIR™ (levofloxacin inhalation solution) in Canada for the Treatment of Specific Lung Infections in Adults with Cystic Fibrosis
Dec 8, 2016 04:10PM Horizon Pharma plc to Participate in Investor Conference in December
Dec 8, 2016 07:01AM Horizon Pharma (HZNP) Announces ACTIMMUNE Phase 3 in FA Missed Primary Endpoint
Dec 8, 2016 07:00AM Horizon Pharma plc Announces Topline Results from Phase 3 Study of  ACTIMMUNE® (interferon gamma-1b) in Friedreich's Ataxia
Dec 7, 2016 07:40AM Horizon Pharma (HZNP), Sobi Enter Ravicti, Ammonaps Distribution Agreement
Dec 7, 2016 07:36AM Sobi and Horizon Pharma enter five-year distribution agreement for Ravicti® and Ammonaps® outside the United States
Nov 14, 2016 07:05AM Horizon Pharma (HZNP) Announces Presentation of Significant Retrospective KRYSTEXXA Data
Nov 14, 2016 07:00AM Horizon Pharma plc Presents Data on KRYSTEXXA® (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting
Nov 11, 2016 09:00AM Horizon Pharma plc Selected as One of Chicago Tribune's 2016 Top Workplaces
Nov 7, 2016 07:00AM Horizon Pharma plc Announces Third-Quarter 2016 Financial Results
Nov 4, 2016 07:00AM Horizon Pharma plc to Participate in Investor Conferences in November
Nov 3, 2016 07:00AM Horizon Pharma plc Announces Availability of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in Canada
Oct 25, 2016 08:41AM Horizon Pharma (HZNP) Announces Completion of Raptor Pharma (RPTP) Acquisition
Oct 25, 2016 08:40AM Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.
Oct 13, 2016 07:00AM Horizon Pharma plc Named One of the Country's Best Medium Workplaces by Fortune Magazine
Oct 11, 2016 04:05PM Horizon Pharma plc to Host Third-Quarter 2016 Conference Call and Webcast on November 7, 2016
Oct 11, 2016 09:19AM Pre-Open Stock Movers 10/11: (KMPH) (SUPN) (TWLO) Higher; (RCII) (ILMN) (LITE) Lower (more...)
Sep 29, 2016 08:03AM Horizon Pharma (HZNP) Enters Rebate Agreement with Prime Therapeutics
Sep 29, 2016 08:00AM Horizon Pharma plc Provides Update on PBM Formulary Status for Primary Care Medicines
Sep 12, 2016 07:01AM Horizon Pharma plc (HZNP) to Acquire Raptor Pharmaceutical (RPTP) for $800M
Sep 12, 2016 07:00AM Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business
Sep 6, 2016 07:00AM Horizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference
Aug 18, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets
Aug 8, 2016 07:00AM Horizon Pharma plc Announces Second-Quarter 2016 Financial Results
Jul 7, 2016 07:00AM Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016
Jun 29, 2016 07:01AM Horizon Pharma (HZNP) Announces Submission of RAVICTI sNDA o Expand Age Range for Management of Urea Cycle Disorders
Jun 29, 2016 07:00AM Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid to Expand Age Range for Management of Urea Cycle Disorders
Jun 27, 2016 04:15PM Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes
Jun 2, 2016 07:00AM Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference
Jun 1, 2016 07:08AM Horizon Pharma (HZNP) Receives USPTO Notice of Allowance on Patent Related to VIMOVO
Jun 1, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
May 19, 2016 07:01AM Horizon Pharma (HZNP) to Acquire Global Interferon Gamma-1b Rights from Boehringer Ingelheim
May 19, 2016 07:00AM Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH
May 18, 2016 05:45PM Horizon Pharma plc to Participate in UBS Global Healthcare Conference
May 12, 2016 08:00AM Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's Association Luminary
May 12, 2016 07:07AM Horizon Pharma (HZNP) Settles PENNSAID Patent Dispute
May 12, 2016 07:00AM Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w Patent Litigation With Teligent, Inc.
May 11, 2016 07:02AM Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for KRYSTEXXA-Related Patent
May 11, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of Allowance With Claims Covering KRYSTEXXA(R) (pegloticase)
May 9, 2016 07:00AM Horizon Pharma plc Announces First-Quarter 2016 Financial Results
May 5, 2016 08:40AM Horizon Pharma (HZNP) Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE
May 5, 2016 08:30AM Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia
May 4, 2016 07:04AM UPDATE: Horizon Pharma (HZNP) Receives Three Additional USPTO Notice of Allowances Related to Diclofenac
May 4, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Three Additional Notices of Allowance With Claims Covering PENNSAID(R) (diclofenac sodium topical solution) 2% w/w
May 3, 2016 07:00AM Horizon Pharma plc to Present at Two Investor Conferences in May
Apr 25, 2016 07:01AM Horizon Pharma (HZNP) Settles With Amneal Pharmaceuticals over PENNSAID
Apr 25, 2016 07:00AM Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w Patent Litigation With Amneal Pharmaceuticals LLC
Apr 18, 2016 07:00AM Horizon Pharma plc to Host First-Quarter 2016 Conference Call and Webcast on May 9, 2016
Apr 4, 2016 07:00AM Horizon Pharma plc Named to Crain's Chicago Business First Ever 2016 "Best Places To Work for Women Over 35" List
Mar 21, 2016 07:01AM Horizon Pharma (HZNP) Receives Approval in Canada for RAVICTI as Urea Cycle Disorders Treatment
View More Recent Stories View Older Stories